ELDN
Eledon Pharmaceuticals, Inc.Company with tickers: ELDN
CIK
1404281
CUSIP
28617K101
Shares Outstanding
77,187,823
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $21,181,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $17,197,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-21,181,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-39,025,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |